Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
PAREXEL International Corporation (Nasdaq: PRXL) announced today that its Board of Directors has approved a stock repurchase program authorizing the...
PAREXEL International Corporation (NASDAQ: PRXL) announced today that Ingo Bank, Senior Vice President and Chief Financial Officer, will discuss...
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that its Board of Directors...
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today launched the next generation of its...
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced expanded services and...
PAREXEL International Corporation (NASDAQ: PRXL) will release financial results for the Fourth Quarter and Fiscal Year 2015 on Wednesday, August 5th, ...
In conjunction with its Investor Day being held tomorrow, PAREXEL International Corporation (Nasdaq: PRXL) has updated its forward-looking guidance...
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today launched next generation risk-based...
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that it will provide a live...
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that Alberto Grignolo, PhD,...
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that several of its experts...
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced enhancements to its...
PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the Goldman Sachs Healthcare Conference in Palos...
PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the UBS Healthcare Conference on Monday, May 18, 2015, ...
PAREXEL International Corporation (NASDAQ: PRXL) today reported financial results for the third quarter of Fiscal Year 2015, which ended on March 31, ...
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that Partnerships in Clinical ...
PAREXEL International (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today announced that it has been awarded a 2015 Gold...
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced three new academic programs...
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today introduced the latest version of its...
PAREXEL International Corporation (Nasdaq: PRXL), a global clinical research organization, announced today that the Company has signed a definitive...
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that it has been named for...
PAREXEL International Corporation (NASDAQ: PRXL) will release financial results for the Third Quarter of Fiscal Year 2015 on Wednesday, April 29th,...
PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the Barclay's Global Healthcare Conference on Tuesday, ...
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced the continued expansion of...
PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced it has been recognized among...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.